SCHEMBL24324366

SCHEMBL24324366

CCCc1cccc([C@@H](C)N)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 4/20 0.41
SLC6A2 P23975 2/20 0.41
SIGMAR1 Q99720 2/20 0.41
MAOA P21397 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
CYP2A6 P11509 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
PNMT P11086 1/20 0.39
KIF11 P52732 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
NOS1 P29475 2/20 0.38
NOS2 P35228 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10338275 0.85 TAAR1 (0.55) TAAR1SLC6A2SIGMAR1MAOASLC6A4
SCHEMBL29342899 0.84 TAAR1 (0.43) TAAR1SLC6A2SIGMAR1MAOASLC6A4
SCHEMBL7887272 0.84 TAAR1 (0.43) TAAR1SLC6A2SIGMAR1MAOASLC6A4
SCHEMBL11797022 0.84 CTSS (0.43) SIGMAR1KIF11GRIN2DGRIN3BGRIN1
SCHEMBL26008372 0.84 TAAR1 (0.43) TAAR1SLC6A2SIGMAR1MAOASLC6A4
SCHEMBL9784597 0.83 CYP4F2 (0.44) TAAR1SLC6A2SIGMAR1MAOASLC6A4
SCHEMBL25112424 0.83 CYP4F2 (0.44) TAAR1SLC6A2SIGMAR1MAOASLC6A4
SCHEMBL7029063 0.81 SLC6A2 (0.47) TAAR1SLC6A2SIGMAR1MAOASLC6A4
SCHEMBL3029503 0.81 KDM4E (0.45) TAAR1SIGMAR1GRIN2DGRIN3BGRIN1
SCHEMBL3029500 0.81 DAO (0.39) SIGMAR1KIF11GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed